Boothbay Fund Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-20,000	Closed	-$473K	–	1842
2025 Q2	$431K	Buy	+20,000	New	+$372K	0.01%	964
2024 Q4	–	Sell	-17,157	Closed	-$264K	–	1446
2024 Q3	$264K	Buy	+17,157	New	+$286K	0.01%	1306
2023 Q2	–	Sell	-12,856	Closed	-$242K	–	1739
2023 Q1	$242K	Sell	12,856 -45,253	-78%	-$862K	0.01%	1630
2022 Q4	$925K	Hold	58,109	–	–	0.03%	930
2022 Q3	$951K	Buy	+58,109	New	+$941K	0.03%	901
2021 Q4	–	Sell	-28,434	Closed	-$472K	–	1815
2021 Q3	$472K	Sell	28,434 -7,193	-20%	-$139K	0.02%	1120
2021 Q2	$869K	Buy	35,627 +18,225	+105%	+$411K	0.03%	767
2021 Q1	$449K	Buy	17,402 +11,621	+201%	+$512K	0.02%	991
2020 Q4	$309K	Sell	5,781 -891	-13%	-$44.2K	0.02%	939
2020 Q3	$275K	Buy	+6,672	New	+$288K	0.02%	832
2018 Q4	–	Sell	-14,893	Closed	-$309K	–	636
2018 Q3	$309K	Buy	+14,893	New	+$234K	0.04%	496